The Maryland company, which has never brought a vaccine to market, has started its Phase 3 trial in the United Kingdom, with plans to begin in the United States in October.
from Health https://ift.tt/3mOXkF8
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment